Importantly, several non-vitamin D agents preserve klotho in CKD: The decline in klotho expression in CKD can be mitigated by therapeutic agents targeting the primary pathogenic drivers: hypertension and inflammation [104,105]. Here, KL is linked to chronic kidney disease.